Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

793
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
793
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

111
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
111
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

153
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
153
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

174
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
174
Human Genetics01:28

Human Genetics

643
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
643
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

382
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
382

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Multigenerational Consequences of Prenatal Exposure to Benzophenone-3 Demonstrate Sex- and Region-Dependent Neurotoxic and Pro-Apoptotic Effects in Mouse Brain.

Toxics·2025
Same author

Correction: Psychedelics action and schizophrenia.

Pharmacological reports : PR·2024
Same author

Limbic System Response to Psilocybin and Ketamine Administration in Rats: A Neurochemical and Behavioral Study.

International journal of molecular sciences·2024
Same author

Psychedelics action and schizophrenia.

Pharmacological reports : PR·2023
Same author

TC-G 1008 facilitates epileptogenesis by acting selectively at the GPR39 receptor but non-selectively activates CREB in the hippocampus of pentylenetetrazole-kindled mice.

Cellular and molecular life sciences : CMLS·2023

Related Experiment Video

Updated: Aug 5, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.7K

Epigenetic Targets in Schizophrenia Development and Therapy.

Agnieszka Wawrzczak-Bargieła1, Wiktor Bilecki1, Marzena Maćkowiak1

  • 1Department of Pharmacology, Laboratory of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.

Brain Sciences
|March 29, 2023
PubMed
Summary
This summary is machine-generated.

Epigenetic mechanisms like DNA methylation and non-coding RNAs are altered in schizophrenia. These epigenetic changes are crucial for understanding antipsychotic drug action and developing new treatments for treatment-resistant schizophrenia.

Keywords:
adolescenceanimal modelsantipsychoticsenvironmentgeneticshuman studiesneurodevelopmentpharmacotherapypsychosistreatment-resistance

More Related Videos

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
08:04

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Published on: November 19, 2020

6.5K
A Chromatin Assay for Human Brain Tissue
11:31

A Chromatin Assay for Human Brain Tissue

Published on: March 21, 2008

13.0K

Related Experiment Videos

Last Updated: Aug 5, 2025

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
13:47

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

9.7K
Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
08:04

Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells

Published on: November 19, 2020

6.5K
A Chromatin Assay for Human Brain Tissue
11:31

A Chromatin Assay for Human Brain Tissue

Published on: March 21, 2008

13.0K

Area of Science:

  • Neuroscience
  • Psychiatry
  • Genetics

Background:

  • Schizophrenia is a lifelong neurodevelopmental disorder with complex etiology.
  • Epigenetic dysregulation, including DNA methylation, histone modifications, and non-coding RNAs, is increasingly implicated in schizophrenia's pathophysiology.
  • Current understanding of schizophrenia's development and treatment remains incomplete.

Purpose of the Study:

  • To review the epigenetic background of schizophrenia.
  • To investigate the role of epigenetic regulation in schizophrenia development and severity.
  • To explore epigenetic modifications as potential therapeutic targets for schizophrenia.

Main Methods:

  • Systematic literature review of epigenetic mechanisms in schizophrenia.
  • Analysis of data from online databases (PubMed, Scopus).
  • Review of preclinical and clinical results on antipsychotic effects on epigenetic regulation.

Main Results:

  • Evidence suggests significant alterations in epigenetic regulation in individuals with schizophrenia.
  • Epigenetic modifications play a key role in the mechanism of action of antipsychotic medications.
  • Antipsychotic treatments demonstrate effects on epigenetic dysfunctions observed in schizophrenia.

Conclusions:

  • Epigenetic mechanisms are demonstrably altered in schizophrenia.
  • Epigenetic modifications are integral to the efficacy of antipsychotic therapies.
  • Further research is needed to establish the role of epigenetics in schizophrenia treatment and develop novel therapeutic strategies for treatment-resistant cases.